Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure.
Mulder
J E
JE
Endocrine Division, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
D000328:Adult; D015519:Bone Density / Q000187:drug effects / Q000528:radiation effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002648:Child; D016889:Endometrial Neoplasms / Q000139:chemically induced; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010024:Osteoporosis / Q000517:prevention & control; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced / Q000188:drug therapy*; D018570:Risk Assessment; D017741:Survivors; D013733:Testicular Diseases / Q000139:chemically induced / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use
D013739:Testosterone